vs
Side-by-side financial comparison of SharpLink Gaming, Inc. (SBET) and STRATA Skin Sciences, Inc. (SSKN). Click either name above to swap in a different company.
SharpLink Gaming, Inc. is the larger business by last-quarter revenue ($10.8M vs $9.3M, roughly 1.2× STRATA Skin Sciences, Inc.). SharpLink Gaming, Inc. runs the higher net margin — 961.6% vs 0.6%, a 961.0% gap on every dollar of revenue. On growth, SharpLink Gaming, Inc. posted the faster year-over-year revenue change (1129.9% vs -3.0%). STRATA Skin Sciences, Inc. produced more free cash flow last quarter ($-551.0K vs $-6.3M).
Bonne Terre Limited is a British-based gambling company, owned by Flutter Entertainment, with headquarters in Leeds, West Yorkshire and offices in Solihull. Sky Betting & Gaming consists of five core brands: Sky Bet, Sky Vegas, Sky Casino, Sky Poker and Sky Bingo.
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
SBET vs SSKN — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.8M | $9.3M |
| Net Profit | $104.3M | $58.0K |
| Gross Margin | — | 61.8% |
| Operating Margin | — | 5.3% |
| Net Margin | 961.6% | 0.6% |
| Revenue YoY | 1129.9% | -3.0% |
| Net Profit YoY | 11880.2% | 101.3% |
| EPS (diluted) | $0.62 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $9.3M | ||
| Q3 25 | $10.8M | $6.9M | ||
| Q2 25 | $697.3K | $7.7M | ||
| Q1 25 | $741.7K | $6.8M | ||
| Q4 24 | $823.1K | $9.6M | ||
| Q3 24 | $881.7K | $8.8M | ||
| Q2 24 | $981.3K | $8.4M | ||
| Q1 24 | $975.9K | $6.8M |
| Q4 25 | — | $58.0K | ||
| Q3 25 | $104.3M | $-1.6M | ||
| Q2 25 | $-103.4M | $-2.6M | ||
| Q1 25 | $-974.9K | $-2.1M | ||
| Q4 24 | — | $-4.6M | ||
| Q3 24 | $-885.1K | $-2.1M | ||
| Q2 24 | $-463.0K | $-91.0K | ||
| Q1 24 | $12.4M | $-3.4M |
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 60.4% | ||
| Q2 25 | 30.0% | 56.2% | ||
| Q1 25 | 17.8% | 53.5% | ||
| Q4 24 | 20.2% | 61.4% | ||
| Q3 24 | 19.6% | 60.1% | ||
| Q2 24 | 28.5% | 59.0% | ||
| Q1 24 | 29.4% | 45.6% |
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | -16.9% | ||
| Q2 25 | -14826.0% | -30.1% | ||
| Q1 25 | -124.8% | -25.0% | ||
| Q4 24 | — | -44.7% | ||
| Q3 24 | -90.4% | -18.2% | ||
| Q2 24 | -122.8% | -5.7% | ||
| Q1 24 | -172.6% | -42.7% |
| Q4 25 | — | 0.6% | ||
| Q3 25 | 961.6% | -23.4% | ||
| Q2 25 | -14832.1% | -33.6% | ||
| Q1 25 | -131.4% | -31.2% | ||
| Q4 24 | — | -47.6% | ||
| Q3 24 | -100.4% | -23.6% | ||
| Q2 24 | -47.2% | -1.1% | ||
| Q1 24 | 1265.5% | -49.8% |
| Q4 25 | — | $0.14 | ||
| Q3 25 | $0.62 | $-0.36 | ||
| Q2 25 | $-4.27 | $-0.62 | ||
| Q1 25 | $-1.84 | $-0.51 | ||
| Q4 24 | — | $-2.01 | ||
| Q3 24 | $-3.02 | $-0.51 | ||
| Q2 24 | $-1.35 | $-0.03 | ||
| Q1 24 | $40.31 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $7.9M |
| Total DebtLower is stronger | — | $15.3M |
| Stockholders' EquityBook value | $3.1B | $2.9M |
| Total Assets | $3.1B | $30.5M |
| Debt / EquityLower = less leverage | — | 5.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $7.9M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $6.0M | ||
| Q1 25 | — | $6.5M | ||
| Q4 24 | — | $7.3M | ||
| Q3 24 | — | $7.1M | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | — | $5.2M |
| Q4 25 | — | $15.3M | ||
| Q3 25 | — | $15.3M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | $0 | $15.0M | ||
| Q3 24 | $0 | $15.0M | ||
| Q2 24 | $0 | $15.0M | ||
| Q1 24 | — | $15.0M |
| Q4 25 | — | $2.9M | ||
| Q3 25 | $3.1B | $1.3M | ||
| Q2 25 | $452.5M | $532.0K | ||
| Q1 25 | $2.1M | $3.0M | ||
| Q4 24 | $2.1M | $5.0M | ||
| Q3 24 | $2.0M | $9.4M | ||
| Q2 24 | $2.8M | $9.5M | ||
| Q1 24 | $2.9M | $9.4M |
| Q4 25 | — | $30.5M | ||
| Q3 25 | $3.1B | $30.7M | ||
| Q2 25 | $453.9M | $29.5M | ||
| Q1 25 | $2.8M | $33.0M | ||
| Q4 24 | $2.6M | $34.9M | ||
| Q3 24 | $2.9M | $39.4M | ||
| Q2 24 | $3.8M | $38.8M | ||
| Q1 24 | $5.4M | $39.2M |
| Q4 25 | — | 5.28× | ||
| Q3 25 | — | 11.65× | ||
| Q2 25 | — | 28.20× | ||
| Q1 25 | — | 5.04× | ||
| Q4 24 | 0.00× | 3.02× | ||
| Q3 24 | 0.00× | 1.60× | ||
| Q2 24 | 0.00× | 1.58× | ||
| Q1 24 | — | 1.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.3M | $-239.0K |
| Free Cash FlowOCF − Capex | $-6.3M | $-551.0K |
| FCF MarginFCF / Revenue | -57.9% | -5.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.4% |
| Cash ConversionOCF / Net Profit | -0.06× | -4.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-239.0K | ||
| Q3 25 | $-6.3M | $-64.0K | ||
| Q2 25 | $-1.6M | $-1.9M | ||
| Q1 25 | $-514.1K | $-550.0K | ||
| Q4 24 | $-22.8M | $703.0K | ||
| Q3 24 | $-591.2K | $-302.0K | ||
| Q2 24 | $-1.7M | $591.0K | ||
| Q1 24 | $-19.3M | $-804.0K |
| Q4 25 | — | $-551.0K | ||
| Q3 25 | $-6.3M | $-1.1M | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $-749.0K | ||
| Q4 24 | $-22.8M | $199.0K | ||
| Q3 24 | — | $-364.0K | ||
| Q2 24 | — | $246.0K | ||
| Q1 24 | $-19.3M | $-1.5M |
| Q4 25 | — | -5.9% | ||
| Q3 25 | -57.9% | -15.6% | ||
| Q2 25 | — | -26.1% | ||
| Q1 25 | — | -11.0% | ||
| Q4 24 | -2772.0% | 2.1% | ||
| Q3 24 | — | -4.1% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | -1977.2% | -22.6% |
| Q4 25 | — | 3.4% | ||
| Q3 25 | 0.0% | 14.7% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | 0.2% | 5.3% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 4.1% | ||
| Q1 24 | 0.2% | 10.7% |
| Q4 25 | — | -4.12× | ||
| Q3 25 | -0.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBET
| ETH Staking Segmet | $10.3M | 95% |
| Other | $569.8K | 5% |
SSKN
| Dermatology Recurring Procedures | $6.1M | 65% |
| Dermatology Procedures Equipment | $3.2M | 35% |
